Highlights
NASDAQ: IFRX       Fireman B.V.
Last Price Today's Change   Day's Range   Trading Volume
2.41   +0.01 (0.42%)  2.32 - 2.44  178,789

Overview

 
Avg Volume (4 weeks):605,240
4 Weeks Range:2.18 - 3.10
4 Weeks Price Volatility (%):
25.00%
52 Weeks Range:2.17 - 53.10
52 Weeks Price Volatility (%):
0.47%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

InflaRx NV is a clinical-stage biopharmaceutical company is focused on applying proprietary anti-C5a technology to discover and develop specific inhibitors of the complement activation factor known as C5a. The lead product candidate of the company is IFX-1, which is developed for the treatment of Hidradenitis Suppurativa, a rare and chronic debilitating systemic inflammatory skin disease. The company's proprietary anti-C5a technology is an inflammatory mediator involved in the progression of a variety of autoimmune and other inflammatory diseases. It is also developing IFX-1 for the treatment of AAV, a life-threatening autoimmune disease associated with powerful inflammatory flares that impair kidney function and lead to fatal organ dysfunction.

  Be the first to like this.
 


 

2956  2578  423  3020 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.884+0.074 
 CHK 0.698-0.004 
 AMD 38.395+0.875 
 CSCO 44.72-3.74 
 AABA 19.630.00 
 SNNA 0.316+0.156 
 CPE 4.315-0.145 
 NOK 3.36-0.11 
 NIO 1.755-0.145 
 AMRN 21.490.00 
Partners & Brokers